Helio Health
Helio Genomics Sister Firm LAMH Receives NMPA Approval in China for Blood-Based Liver Cancer Test
The liquid biopsy assay is a modified version of Helio's HelioLiver test that is tailored to the unique genetic makeup of the Asia-Pacific population.